Identification
Personal identification
- Full name
- João Conde
Citation names
- Conde, João
Author identifiers
- Ciência ID
- A71C-B10E-255E
- ORCID iD
- 0000-0001-8422-6792
- Google Scholar ID
- https://scholar.google.com/citations?user=H2Flb9kAAAAJ&hl=en
- Researcher Id
- F-2231-2011
- Scopus Author Id
- 56992468300
Email addresses
- joao.conde@nms.unl.pt (Professional)
Websites
- https://www.conde-nanolab.com/ (Professional)
- https://scholar.google.com/citations?user=H2Flb9kAAAAJ&hl=en (Scholar)
- https://condeart.carbonmade.com/ (Blog)
- https://www.linkedin.com/in/joao-conde-8b52a4192/ (Personal)
- https://twitter.com/CNanolab?lang=en (Professional)
- https://publons.com/researcher/1358364/joao-conde/ (Professional)
Knowledge fields
- Engineering and Technology - Nano-technology
- Medical and Health Sciences - Medical Biotechnology - Biomaterials
- Medical and Health Sciences - Clinical Medicine - Oncology
- Medical and Health Sciences - Basic Medicine - Human Genetics
- Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
- Medical and Health Sciences - Medical Biotechnology - Gene-based Diagnostics and Therapeutic Interventions
- Engineering and Technology - Materials Engineering - Materials Engineering
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Spanish; Castilian | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | Upper intermediate (B2) |
Portuguese (Mother tongue) |
Education
Degree | Classification | |
---|---|---|
2010/01/01 - 2014/01/01
Concluded
|
Biology - Nanobiotechnology (Doutoramento)
Universidade Nova de Lisboa, Portugal
Universidad de Zaragoza, Spain |
|
2009
Concluded
|
Biologia (Doutoramento)
Major in Especialidade: Biotecnologia
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal
"Cancer Theragnostics-Multifunctional gold nanoparticles for diagnostics and therapy" (THESIS/DISSERTATION)
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2020/02 - Current | Principal Investigator (Research) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2017/09/01 - 2020/01/31 | Auxiliary Researcher (Research) | Instituto de Medicina Molecular, Portugal |
Instituto de Medicina Molecular, Portugal | ||
2016/05/01 - 2017/05/01 | Postdoc (Research) | Queen Mary University of London, United Kingdom |
Queen Mary University of London School of Engineering and Materials Science, United Kingdom | ||
2014/03/01 - 2017/05/01 | Postdoc (Research) | Massachusetts Institute of Technology, United States |
Massachusetts Institute of Technology, United States (...) |
||
2009 - 2010 | Researcher (Research) | Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal |
2007 - 2009 | Research Trainee (Research) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2020/02/01 - Current | Assistant Professor (University Teacher) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2010/01/01 - 2014/01/01 | PhD Student | Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2023 - 2026 | RNA-based cancer therapies
European Innovation Council – EIC Transition Grant
Co-Principal Investigator (Co-PI)
|
Ongoing
|
2021/01/01 - 2024/01/01 | Biomimetic cell membrane-coated vitamin E-based micelles for multimodal pancreatic cancer nanotheranostics
PTDC/BTM-MAT/4738/2020
PTDC/BTM-MAT/4738/2020
Principal investigator
Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal
Universidade de Coimbra, Portugal Universidade Nova de Lisboa, Portugal University of Strathclyde, United Kingdom Universidade de Santiago de Compostela, Spain |
N/A Fundação para a Ciência e a Tecnologia Ongoing
|
2014/05 - 2017/04 | Marie Curie Grant - CancerHydrogelPatch
FP7-PEOPLE-2013-IOF
Post-doc Fellow
|
EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions |
2016 - 2017 | SuprHApolymers - Engineering self-assembly of hyaluronan-based glycopolymers with peptides
631871
Researcher
|
|
2012 - 2015 | Silence is golden (siAu) - silencing the silencers via multifunctional gold nanoconjugates towards cancer therapy
PTDC/BBB-NAN/1812/2012
Research Fellow
Fundação para a Ciência e a Tecnologia, Portugal
|
Concluded
|
2010/01 - 2014/01 | FCT PhD Grant - Cancer Theranostics: Multifunctional gold nanoparticles for diagnostics and therapy
SFRH/BD/62957/2009
|
Fundação para a Ciência e a Tecnologia |
2012 - 2014 | NANOTRUCK- Multifunctional gold nanoparticles for gene therapy.
ERANET-NANOSCIERA NANOTRUC
ERANET-NANOSCIERA NANOTRUC
PhD Student Fellow
|
N/A
Concluded
|
2010 - 2013 | Nanosystems for delivery of caged compounds
PTDC/QUI-QUI/ 112597/2009
Research Fellow
Fundação para a Ciência e a Tecnologia, Portugal
|
Concluded
|
2009 - 2012 | Sensitive and selective detection of DNA/RNA based on functionalized gold nanoparticles - application to pathogen detection;
mutation detection and RNA quantification
PTDC/BIO/66514/2006
Research Fellow
Fundação para a Ciência e a Tecnologia, Portugal
|
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2020/02/01 - 2025/01/31 | Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic
circuits.
848325
Principal investigator
Universidade Nova de Lisboa, Portugal
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
European Commission European Research Council Ongoing
|
2022/01/01 - 2024/12/31 | combined immUNotherapeutIC approach for targeting bone marrow microenvironment in Multiple Myeloma
PTDC/MED-ONC/1215/2021
Fundação Champalimaud, Portugal
Universidade Nova de Lisboa, Portugal Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
2023/01/01 - 2024/06/30 | Patient-derived lung cancer organoids for recreating tumor spread through AIR spaces phenomenon
2022.07775.PTDC
Universidade Nova de Lisboa, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019/03/01 - 2020/01/31 | Hydrogel scaffolds for delivery of gene therapies
CEECIND/01688/2017/CP1396/CT0006
Researcher
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2019/01/01 - 2019/12/31 | Instituto de Medicina Molecular
UID/BIM/50005/2019
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2011/03/01 - 2014/08/31 | NANOLIGHT - Nanosystems for delivery of caged compounds
PTDC/QUI-QUI/112597/2009
Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal
Associação para a Inovação e Desenvolvimento da FCT, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2011/01/01 - 2013/12/31 | Strategic Project - UI 9 - 2011-2012
PEst-OE/SAU/UI0009/2011
Universidade NOVA de Lisboa NOVA Medical School, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2009/07/01 - 2012/06/30 | Nanotruck - Multifunctional Gold Nanoparticles for Gene Therapy
NanoSciERA/0001/2008
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal
Universidade Nova de Lisboa Centro de Toxicogenómica e Saúde Humana, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
Other
Designation | Funders | |
---|---|---|
2018 - 2019 | Recombinant albumin conjugates for cancer therapy
Albumedix
Researcher
Albumedix, United Kingdom
|
Concluded
|
Outputs
Publications
Book chapter |
|
Book review |
|
Conference poster |
|
Edited book |
|
Journal article |
|
Thesis / Dissertation |
|
Website |
|
Intellectual property
Patent |
|
Other
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2021/07/01 | Biotech in Action S2: Water Cooler Talk - Massachusetts Institute of Technology (MIT), Harvard–MIT Division for Health Sciences and Technology, July 2021, Boston, Massachusetts, USA (Invited). | Biotech in Action S2: Water Cooler Talk
Massachusetts Institute of Technology (MIT), Harvard–MIT Division for Health Sciences and Technology (Boston, United States)
|
2021/06/01 | “The story behind my path in Cancer NanoMedicine” at the PostDoc ShowCase 2nd edition - Department of Pharmacy, University of Naples Federico II, June 2021, Italy (Invited). | PostDoc ShowCase 2nd edition
Department of Pharmacy, University of Naples (Napoli, Italy)
|
2021/05/01 | 9th Session IST- MedNetworking – To see or not to see: How Nanotechnology is redefining Medicine, Instituto Superior Técnico (IST), May 2021, Portugal (Invited). | 9th Session IST- MedNetworking – To see or not to see: How Nanotechnology is redefining Medicine
Instituto Superior Técnico (IST) (Lisbon, Portugal)
|
2020/01/01 | Keynote Speaker - 13º Encontro Nacional de Química Orgânica/6º Encontro Nacional de Química Terapêutica (13ENQO/6ENQT), January 2020, Portugal (Invited). | Keynote Speaker - 13º Encontro Nacional de Química Orgânica/6º Encontro Nacional de Química Terapêutica (13ENQO/6ENQT)
Universidade de Aveiro (Aveiro, Portugal)
|
2020/01 | Why going Nano on Cancer Healthcare? | 13º Encontro Nacional de Química Orgânica/6º Encontro Nacional de Química Terapêutica (13ENQO/6ENQT)
(Aveiro)
|
2017/03 | CANCER : inviting BIOMATERIALS to waltz with the devil | Seminar
University of Glasgow, Institute of Molecular Cell and Systems Biology (Glasgow, United Kingdom)
|
2017/02 | Smart Biomaterials for Cancer Nanomedicine | Nanomedicine Seminars
Trinity College Dublin, School of Medicine (Dublin, Ireland)
|
2016/03 | The Nano versus Cancer | Seminar
Massachusetts Institute of Technology (Cambridge, Massachusetts , United States)
|
2012/02 | Cancer Theranostics: Multifunctional Gold Nanoparticles for Diagnosis and Therapy | Miami 2012 Winter Symposium: Nanotechnology in Biomedicine
Nature Conferences (Miami, United States)
|
2009 | Genetic polymorphisms involved in sporadic Breast cancer | XXXIV Genetic Journeys
Human Cancer Genetics and Genotoxicity, Portuguese Society of Human Genetics (Lisboa, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2022 - 2022 | In vitro recapitulation of breast tumor microenvironment for personalized theranostic strategies
Supervisor
|
Biomedicina (associação) (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2022 - 2022 | Polymeric nanoparticles for local delivery of multicolor genetic circuits in breast cancer
Supervisor
|
Investigação Biomédica (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2021 - 2021 | Gold-nanoconjugates as an approach to target microRNAs and immune-infiltrating cells involved in lung cancer progression
Supervisor
|
Biomedicina (associação) (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2021 | Transcriptional Program Biosensors for Human Cell Type and State Diagnosis
(Thesis) Arguer
|
Benilde Francisco Pondeca (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2020 | Theranostic Nanocomposites for Cancer Immunotherapy
(Thesis) Main arguer
|
Tomás Bauleth-Ramos (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2020 - Current | Global Burden Disease (GBD), Institute for Health Metrics and Evaluation (IHME), University of Washington (US). | Active collaborator |
Interview (newspaper / magazine)
Activity description | Newspaper / Forum | |
---|---|---|
2021 | "Na quimioterapia só 5% a 10% do fármaco chega ao local. Na nanotecnologia não há dispersão, é mais eficaz e menos tóxico" João Conde, professor de Genética, investigador do Centro de Estudos de Ciências Médicas (ToxOmics), da Faculdade de Ciências Médicas, Universidade Nova de Lisboa, defende que as farmacêuticas devem apoiar a investigação e que a nanomedicina é uma aposta de futuro. | Jornal de Noticias |
Journal scientific committee
Journal title (ISSN) | Publisher | |
---|---|---|
2021 - Current | Journal of Functional Biomaterials | MDPI |
2021 - Current | Materials | MDPI |
2021 - Current | Exploration | Wiley |
2021 - Current | VIEW | Wiley |
2021 - Current | Frontiers Genetics - Toxicogenomics | Frontiers |
2020 - Current | Journal of Nanotheranostics | MDPI |
2016 - Current | Nano Biomedicine and Engineering Journal | |
2015 - Current | Frontiers in Bioengineering and Biotechnology | |
2015 - Current | Frontiers in Molecular Biosciences (2296-889X) | Frontiers Media SA |
2015 - Current | Frontiers in Materials (2296-8016) | Frontiers Media SA |
2014 - Current | Frontiers in Chemistry (2296-2646) | Frontiers Media SA |
Distinctions
Award
2023 | 2023 World Top 2% Scientists list by Stanford University
Stanford University, United States
|
2022 | World Top 2% Scientists list by Stanford University
Stanford University, United States
|
2021 | Nanomaterials 2020 Young Investigator Award
Multidisciplinary Digital Publishing Institute AG, Switzerland
|
2021 | Top2% Most cited in Nanoscience/Nanotechnology
Public Library of Science, United States
|
2020 | Biomaterials Science Emerging Investigator |
2019 | ERC Starting Grant - European Research Council
European Research Council, Belgium
|
2018 | Junior Investigator: FCT Stimulus of Scientific Employment |
2017 | Wellcome Image Awards 2017: Wellcome Trust, UK |
2016 | Nano-Micro Letters Researcher Award, Nature Research Society |
2016 | National Cancer Institute Image award: Cancer close up, USA |
2014 | Marie Curie International Outgoing Fellowship for Career Development, Marie Sklodowska- Curie actions (FP7-PEOPLE-2013-IOF) |
2009 | PhD Fellowship - National Science Foundation Portugal - PhD Grant (FCT, SFRH/BD/ 62957/2009) |